These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 22806357)

  • 1. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
    Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
    Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
    Lan T; Kisseleva T; Brenner DA
    PLoS One; 2015; 10(7):e0129743. PubMed ID: 26222337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
    Jiang JX; Chen X; Serizawa N; Szyndralewiez C; Page P; Schröder K; Brandes RP; Devaraj S; Török NJ
    Free Radic Biol Med; 2012 Jul; 53(2):289-96. PubMed ID: 22618020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.
    Paik YH; Iwaisako K; Seki E; Inokuchi S; Schnabl B; Osterreicher CH; Kisseleva T; Brenner DA
    Hepatology; 2011 May; 53(5):1730-41. PubMed ID: 21384410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous 8-hydroxydeoxyguanosine ameliorates liver fibrosis through the inhibition of Rac1-NADPH oxidase signaling.
    Shin SK; Kim KO; Kim SH; Kwon OS; Choi CS; Jeong SH; Kim YS; Kim JH; Chung MH
    J Gastroenterol Hepatol; 2020 Jun; 35(6):1078-1087. PubMed ID: 31907970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity.
    Li Q; Spencer NY; Pantazis NJ; Engelhardt JF
    J Biol Chem; 2011 Nov; 286(46):40151-62. PubMed ID: 21937428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
    Gorin Y; Cavaglieri RC; Khazim K; Lee DY; Bruno F; Thakur S; Fanti P; Szyndralewiez C; Barnes JL; Block K; Abboud HE
    Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1276-87. PubMed ID: 25656366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase.
    Wang M; Abais JM; Meng N; Zhang Y; Ritter JK; Li PL; Tang WX
    Free Radic Biol Med; 2014 Jun; 71():109-120. PubMed ID: 24657416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation.
    Cui W; Matsuno K; Iwata K; Ibi M; Matsumoto M; Zhang J; Zhu K; Katsuyama M; Torok NJ; Yabe-Nishimura C
    Hepatology; 2011 Sep; 54(3):949-58. PubMed ID: 21618578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4.
    Somanna NK; Valente AJ; Krenz M; Fay WP; Delafontaine P; Chandrasekar B
    J Cell Physiol; 2016 May; 231(5):1130-41. PubMed ID: 26445208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase.
    Chéret C; Gervais A; Lelli A; Colin C; Amar L; Ravassard P; Mallet J; Cumano A; Krause KH; Mallat M
    J Neurosci; 2008 Nov; 28(46):12039-51. PubMed ID: 19005069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis.
    De Minicis S; Seki E; Paik YH; Osterreicher CH; Kodama Y; Kluwe J; Torozzi L; Miyai K; Benedetti A; Schwabe RF; Brenner DA
    Hepatology; 2010 Oct; 52(4):1420-30. PubMed ID: 20690191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH Oxidase 1 Mediates Acute Blood Pressure Response to Angiotensin II by Contributing to Calcium Influx in Vascular Smooth Muscle Cells.
    Park JM; Do VQ; Seo YS; Kim HJ; Nam JH; Yin MZ; Kim HJ; Kim SJ; Griendling KK; Lee MY
    Arterioscler Thromb Vasc Biol; 2022 May; 42(5):e117-e130. PubMed ID: 35354309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo.
    Jiang JX; Venugopal S; Serizawa N; Chen X; Scott F; Li Y; Adamson R; Devaraj S; Shah V; Gershwin ME; Friedman SL; Török NJ
    Gastroenterology; 2010 Oct; 139(4):1375-84. PubMed ID: 20685364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.
    Cha JJ; Min HS; Kim KT; Kim JE; Ghee JY; Kim HW; Lee JE; Han JY; Lee G; Ha HJ; Bae YS; Lee SR; Moon SH; Lee SC; Kim G; Kang YS; Cha DR
    Lab Invest; 2017 Apr; 97(4):419-431. PubMed ID: 28165467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review.
    Mortezaee K
    Cell Biochem Funct; 2018 Aug; 36(6):292-302. PubMed ID: 30028028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NADPH oxidases in liver fibrosis.
    Paik YH; Kim J; Aoyama T; De Minicis S; Bataller R; Brenner DA
    Antioxid Redox Signal; 2014 Jun; 20(17):2854-72. PubMed ID: 24040957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease.
    Gray SP; Jha JC; Kennedy K; van Bommel E; Chew P; Szyndralewiez C; Touyz RM; Schmidt HHHW; Cooper ME; Jandeleit-Dahm KAM
    Diabetologia; 2017 May; 60(5):927-937. PubMed ID: 28160092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
    Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.
    Deliyanti D; Wilkinson-Berka JL
    J Neuroinflammation; 2015 Jul; 12():136. PubMed ID: 26219952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.